Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin vs Excimer Light as Adjuvant to Itraconazole in Onychomycosis
NCT06485505Phase 1Recruiting
- Sponsor
- Zagazig University
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of isotretinoin in onychomycosis (3 arms), sponsored by Zagazig University. Primary endpoints: Clinical improvement at 6 months and Fungal culture at 6 months. Started Jul 2024; status: recruiting.
02
Drugs
isotretinoin
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT06485505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06485505.